£19k
−23%vs Apr 2024Active08016198Private limited companyLondon
HEL PHARMA LIMITED
Significant control: Helen Yohannes (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Hel Pharma Limited sell?
Registered activity: Management consultancy activities other than financial management (SIC 70229). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
HEL PHARMA LIMITED is an active private limited company (company number 08016198) incorporated on 2 April 2012, registered in London. Its registered activity is management consultancy activities other than financial management (SIC 70229). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £19k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 23% on the prior period (£25k).
Peer position · net assets
By net assets it sits in the upper half of 31,398 comparable companies in London (median £2,815, upper quartile £34k).
02
Ownership and control
- Mrs Helen Yohannes
- owns 25–50% of shares
- Mr Senay Tesfamariam
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 2 April 201214 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 16 April 2027in 175 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 70229
- Management consultancy activities other than financial management
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £19k | — | — | £1,695 | — | — | 1 |
| 30 April 2024 | £25k | — | — | £2,581 | — | — | 1 |
Current ratio12.5Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £19,492 at 30 April 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 12.5
- Incorporated five or more years agoIncorporated 2 April 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 175 days
- Next accounts duein 99 days
- Accounts period endNet assets £19k · micro accounts
- Accounts period endNet assets £25k · micro accounts
- Incorporated
08
Similar companies in London
- EPI SOLUTIONS LTDLondon · inc. Apr 2012
- EBIT BUSINESS SOLUTIONS LTDLondon · inc. Apr 2012
- ALLSTRUCT LIMITEDLondon · inc. Apr 2012
- KME CONSULTING LIMITEDLondon · inc. Apr 2012
- TELEX LIMITEDFinchley · inc. Apr 2012
- SANCHEZ CONSULTING LIMITEDLondon · inc. Apr 2012
All companies incorporated on 2 April 2012 · in Apr 2012.
09
Reminders for HEL PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.